Nathanael Lafferty
Family Medicine · Spring Hill, TNNPI 1750494969
Payments from drug & device makers
Across 407 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$988
- Pfizer$948
- AstraZeneca$524
- Lilly USA, LLC$480
- Amgen$328
- plus $3K from 38 others
What the payments were for
- Food & beverage$7,185100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$101
How this compares
$7,196 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 299 | $315,791 |
| MounjaroTirzepatide | 203 | $240,224 |
| OzempicSemaglutide | 168 | $188,305 |
| EliquisApixaban | 155 | $177,574 |
| TrulicityDulaglutide | 88 | $134,155 |
| XareltoRivaroxaban | 56 | $77,782 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 78 | $63,234 |
| FarxigaDapagliflozin Propanediol | 56 | $50,983 |
| JanuviaSitagliptin Phosphate | 31 | $40,034 |
| LinzessLinaclotide | 41 | $33,424 |
| RexultiBrexpiprazole | 13 | $19,107 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $18,400 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $17,659 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $16,041 |
| RybelsusSemaglutide | 12 | $15,570 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $480 | $374,379291 claims |
| Boehringer IngelheimJardiance | $133 | $315,791299 claims |
| Novo NordiskOzempic, Rybelsus | $988 | $203,875180 claims |
| PfizerEliquis | $948 | $177,574155 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $304 | $93,874127 claims |
| Johnson & JohnsonXarelto | $88 | $77,78256 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $524 | $76,915106 claims |
| MerckJanuvia, Janumet, Belsomra | $111 | $65,42460 claims |
| AbbVieLinzess | $1,245 | $33,42441 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $12,46216 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $35 | $5,931583 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Spring Hill
- Renee DhillonSpring Hill$18K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.